RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: pancreatic ductal carcinoma
Accession: DOID:3587
browse the term
Definition: A pancreatic carcinoma located_in the pancreatic duct. (DO)
Synonyms: exact_synonym: Duct Cell Carcinoma of the Pancreas; Pancreas Duct-Cell Carcinoma; Pancreas Duct-Cell Carcinomas; Pancreatic Ductal Carcinomas; ductal carcinoma of the pancreas; malignant neoplasm of duct of Wirsung; pancreatic duct cancer; pancreatic duct cell carcinoma
primary_id: MESH:D021441
xref: ICD10CM:C25.3 ; ICD9CM:157.3
For additional species annotation, visit the
Alliance of Genome Resources .
G
ACE
angiotensin I converting enzyme
IEP
mRNA, protein:increased expression:pancreas
RGD
PMID:17481528
RGD:2325211
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ACE2
angiotensin converting enzyme 2
IEP
protein:decreased expression:pancreas
RGD
PMID:19212105
RGD:2325210
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
G
ADAM8
ADAM metallopeptidase domain 8
disease_progression
IEP
mRNA:increased expression:pancreas
RGD
PMID:17979891
RGD:2325243
NCBI chr10:133,262,423...133,276,868
Ensembl chr10:133,262,420...133,276,868
G
ADAM9
ADAM metallopeptidase domain 9
disease_progression
IEP
protein:altered localization:cytoplasm
RGD
PMID:14997207
RGD:2325249
NCBI chr 8:38,996,973...39,105,261
Ensembl chr 8:38,996,754...39,105,445
G
AGR2
anterior gradient 2, protein disulphide isomerase family member
IEP
mRNA:increased expression:pancreas
RGD
PMID:19609859
RGD:2325659
NCBI chr 7:16,791,811...16,804,999
Ensembl chr 7:16,791,811...16,833,433
G
AGTR1
angiotensin II receptor type 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17481528
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
G
ALB
albumin
disease_progression
IEP
RGD
PMID:19011933
RGD:2325677
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
ANXA2
annexin A2
disease_progression
IEP
mRNA, protein:increased expression, altered localization:pancreas, plasma membrane
RGD
PMID:19260470 PMID:16450333
RGD:2317307 , RGD:2325731
NCBI chr15:60,347,151...60,397,986
Ensembl chr15:60,347,134...60,402,883
G
ANXA5
annexin A5
IEP
protein:increased expression:pancreas
RGD
PMID:19488907
RGD:2317538
NCBI chr 4:121,667,946...121,696,980
Ensembl chr 4:121,667,946...121,696,995
G
ANXA8
annexin A8
IEP
mRNA:increased expression:pancreas
RGD
PMID:18223320
RGD:2325735
NCBI chr10:47,467,993...47,991,796
Ensembl chr10:47,460,162...47,484,158
G
APOC1
apolipoprotein C1
IEP
RGD
PMID:15876873
RGD:2325793
NCBI chr19:44,914,325...44,919,346
Ensembl chr19:44,914,247...44,919,349
G
ARG2
arginase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23424623
NCBI chr14:67,619,920...67,651,708
Ensembl chr14:67,619,920...67,651,708
G
BMI1
BMI1 proto-oncogene, polycomb ring finger
ISO IEP
protein:increased expression:pancreas protein:increased expression:exocrine pancreas:
RGD
PMID:19585519 PMID:19585519
RGD:9491843 , RGD:9491843
NCBI chr10:22,321,099...22,331,484
Ensembl chr10:22,321,099...22,331,484
G
C19orf33
chromosome 19 open reading frame 33
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:35142956
NCBI chr19:38,304,251...38,305,006
Ensembl chr19:38,304,164...38,305,006
G
CALR
calreticulin
IEP
protein:increased expression:pancreatic duct
RGD
PMID:15289361
RGD:2326165
NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489
G
CBX7
chromobox 7
disease_progression
IEP
protein:decreased expression:pancreas
RGD
PMID:20185297
RGD:9587360
NCBI chr22:39,130,772...39,152,680
Ensembl chr22:39,120,167...39,152,680
G
CCKAR
cholecystokinin A receptor
IEP
protein:decreased expression:pancreas mRNA:increased expression:pancreatic duct
RGD
PMID:12851875 PMID:9239407
RGD:4110816 , RGD:4110818
NCBI chr 4:26,481,396...26,490,484
Ensembl chr 4:26,481,396...26,490,484
G
CCKBR
cholecystokinin B receptor
IEP
protein:decreased expression:pancreas
RGD
PMID:12851875
RGD:4110816
NCBI chr11:6,259,838...6,272,127
Ensembl chr11:6,259,806...6,272,127
G
CCND1
cyclin D1
severity
IEP
protein:increased expression:pancreas (human)
RGD
PMID:17420962
RGD:13462063
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
G
CD40
CD40 molecule
treatment
IDA IMP IEP
protein:increased expression:dendritic cell
RGD
PMID:21436454 PMID:23983255 PMID:20976171
RGD:5490301 , RGD:11522743 , RGD:5490524
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
G
CDK6
cyclin dependent kinase 6
treatment
IDA
human cells in a mouse model
RGD
PMID:24389175
RGD:13782187
NCBI chr 7:92,604,921...92,836,573
Ensembl chr 7:92,604,921...92,836,573
G
CDKN1A
cyclin dependent kinase inhibitor 1A
disease_progression
IEP
RGD
PMID:17671118
RGD:8662851
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CDKN2A
cyclin dependent kinase inhibitor 2A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24986516
NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
G
CLDN4
claudin 4
IEP
RGD
PMID:15693851
RGD:2317592
NCBI chr 7:73,830,996...73,832,690
Ensembl chr 7:73,799,542...73,832,690
G
CXCL11
C-X-C motif chemokine ligand 11
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24979617
NCBI chr 4:76,033,682...76,036,070
Ensembl chr 4:76,033,682...76,041,415
G
DNMT1
DNA methyltransferase 1
disease_progression
IEP EXP
protein:increased expression:pancreas CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29844410 PMID:19424621
RGD:9588974
NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286
G
DNMT3B
DNA methyltransferase 3 beta
disease_progression
IEP
RGD
PMID:22919364
RGD:9589121
NCBI chr20:32,762,385...32,809,356
Ensembl chr20:32,762,385...32,809,359
G
DTX1
deltex E3 ubiquitin ligase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr12:113,056,730...113,098,025
Ensembl chr12:113,056,730...113,098,028
G
DTX4
deltex E3 ubiquitin ligase 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr11:59,171,430...59,208,588
Ensembl chr11:59,171,430...59,208,588
G
EGF
epidermal growth factor
disease_progression
IEP
protein:increased expression: :
RGD
PMID:18505086
RGD:2317644
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
G
FASLG
Fas ligand
IEP IDA
protein:increased expression:pancreas, liver
RGD
PMID:15375495 PMID:10547193
RGD:2317741 , RGD:2317747
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
G
FGF2
fibroblast growth factor 2
disease_progression
IEP
RGD
PMID:12717266 PMID:18704599
RGD:2317758 , RGD:2317756
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
G
FSCN1
fascin actin-bundling protein 1
disease_progression
IEP
protein:increased expression:pancreas
RGD
PMID:12109856
RGD:2317790
NCBI chr 7:5,592,816...5,606,655
Ensembl chr 7:5,592,816...5,606,655
G
GPNMB
glycoprotein nmb
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24979617
NCBI chr 7:23,246,775...23,275,108
Ensembl chr 7:23,235,967...23,275,108
G
GSTP1
glutathione S-transferase pi 1
resistance
IEP IAGP IDA
mRNA, protein:increased expression:pancreas DNA:methylation: :
RGD
PMID:12488200 PMID:17265526 PMID:16537562
RGD:2317811 , RGD:2317806 , RGD:2317809
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
HDAC1
histone deacetylase 1
disease_progression
IEP
protein:increased expression:pancreas
RGD
PMID:19424621
RGD:9588974
NCBI chr 1:32,292,083...32,333,626
Ensembl chr 1:32,292,083...32,333,635
G
HEATR1
HEAT repeat containing 1
treatment
IMP
RGD
PMID:26676747
RGD:10761108
NCBI chr 1:236,549,005...236,604,516
Ensembl chr 1:236,549,005...236,604,516
G
HES1
hes family bHLH transcription factor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732
G
HEY1
hes related family bHLH transcription factor with YRPW motif 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr 8:79,764,010...79,767,767
Ensembl chr 8:79,762,371...79,767,857
G
HEY2
hes related family bHLH transcription factor with YRPW motif 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr 6:125,749,632...125,761,269
Ensembl chr 6:125,747,664...125,761,269
G
HSPA1A
heat shock protein family A (Hsp70) member 1A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17234771
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
G
HSPA1B
heat shock protein family A (Hsp70) member 1B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17234771
NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
G
IGF1
insulin like growth factor 1
ISO
RGD
PMID:20098680
RGD:2317639
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGF1R
insulin like growth factor 1 receptor
IEP
protein:increased expression:pancreas
RGD
PMID:14506643 PMID:14627343
RGD:2317652 , RGD:2317649
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
G
IL4
interleukin 4
IMP
RGD
PMID:17942922
RGD:2317264
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL4R
interleukin 4 receptor
IEP
protein:increased expression:pancreas
RGD
PMID:17942922
RGD:2317264
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
INS
insulin
IEP
Glucagon/insulin
RGD
PMID:19571666
RGD:2317248
NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221
G
JAG1
jagged canonical Notch ligand 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr20:10,637,684...10,673,999
Ensembl chr20:10,637,684...10,673,999
G
JAG2
jagged canonical Notch ligand 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr14:105,140,995...105,168,776
Ensembl chr14:105,140,982...105,168,824
G
KDM2B
lysine demethylase 2B
severity
IEP
mRNA, protein:increased expression:pancreas (human)
RGD
PMID:23321669
RGD:9588253
NCBI chr12:121,408,461...121,582,279
Ensembl chr12:121,429,096...121,581,023
G
KITLG
KIT ligand
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24979617
NCBI chr12:88,492,793...88,580,471
Ensembl chr12:88,492,793...88,580,851
G
KRAS
KRAS proto-oncogene, GTPase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25347530 PMID:30654191
NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936
G
KRT7
keratin 7
disease_progression
IEP
RGD
PMID:19260470
RGD:2317307
NCBI chr12:52,233,243...52,255,853
Ensembl chr12:52,232,520...52,252,186
G
L1CAM
L1 cell adhesion molecule
severity
IEP
protein:increased expression:pancreas (human)
RGD
PMID:20162456
RGD:6483447
NCBI chr X:153,861,514...153,886,173
Ensembl chr X:153,861,514...153,886,173
G
MAP3K7
mitogen-activated protein kinase kinase kinase 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34686948
NCBI chr 6:90,513,579...90,587,072
Ensembl chr 6:90,513,573...90,587,086
G
MAPK3
mitogen-activated protein kinase 3
treatment
IDA
human cells in mouse model
RGD
PMID:20179210
RGD:14348973
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MCM7
minichromosome maintenance complex component 7
IEP
mRNA, protein:increased expression:pancreatic duct
RGD
PMID:15548371
RGD:2317697
NCBI chr 7:100,092,728...100,101,397
Ensembl chr 7:100,092,233...100,101,940
G
MDM2
MDM2 proto-oncogene
severity onset
IEP IAGP
protein:increased expression:pancreas (human) DNA:snp:promoter, intron:IVS1+309T>G (human)
RGD
PMID:15810085 PMID:19752772
RGD:2317416 , RGD:2317414
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
G
MEN1
menin 1
IEP IDA
protein:decreased expression:pancreas
RGD
PMID:19170121 PMID:19170121
RGD:2317294 , RGD:2317294
NCBI chr11:64,803,516...64,811,294
Ensembl chr11:64,803,510...64,811,294
G
MET
MET proto-oncogene, receptor tyrosine kinase
IEP
protein:increased expression:pancreatic duct (human)
RGD
PMID:7866999
RGD:2317530
NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
G
MGMT
O-6-methylguanine-DNA methyltransferase
susceptibility
IEP IAGP
protein:increased activity, increased expression:ductal adenocarcinoma (human) DNA:missense mutation:cds:p.L84F rs12917 (human)
RGD
PMID:9393761 PMID:16844323
RGD:2317664 , RGD:2317648
NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983
G
MIR142
microRNA 142
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29844410
NCBI chr17:58,331,232...58,331,318
Ensembl chr17:58,331,232...58,331,318
G
MIR873
microRNA 873
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:30654191
NCBI chr 9:28,888,879...28,888,955
Ensembl chr 9:28,888,879...28,888,955
G
MMP2
matrix metallopeptidase 2
severity
IEP
protein:increased expression:pancreas
RGD
PMID:17377415
RGD:2325746
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP9
matrix metallopeptidase 9
IEP
protein:increased expression:blood protein:increased expression:pancreas, serum
RGD
PMID:20332475 PMID:18706098
RGD:2325830 , RGD:2325844
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MSLN
mesothelin
disease_progression
IDA EXP IEP
DNA:hypomethylation:5'UTR CTD Direct Evidence: marker/mechanism protein:increased secretion:serum
CTD RGD
PMID:14576474 PMID:21775916 PMID:25347530 PMID:12874021 PMID:19818733
RGD:2326065 , RGD:2326055
NCBI chr16:760,734...768,865
Ensembl chr16:760,734...768,865
G
MUC1
mucin 1, cell surface associated
disease_progression
IEP IMP IDA
protein:increased expression, altered localization:pancreas
RGD
PMID:14681945 PMID:18713982 PMID:19109152
RGD:2317983 , RGD:2324633 , RGD:2324616
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
G
MUC3A
mucin 3A, cell surface associated
disease_progression
IEP
mRNA:increased expression:pancreas
RGD
PMID:12657964
RGD:2324946
NCBI chr 7:100,949,534...100,968,347
Ensembl chr 7:100,949,534...100,968,347
G
MUC4
mucin 4, cell surface associated
disease_progression
IEP
mRNA:increased expression:pancreas protein:increased expression:pancreas
RGD
PMID:12657964 PMID:16049287
RGD:2324946 , RGD:2324942
NCBI chr 3:195,746,771...195,811,929
Ensembl chr 3:195,746,765...195,811,973
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
disease_progression
IEP
mRNA:increased expression:pancreas
RGD
PMID:7657125 PMID:10227724
RGD:2324986 , RGD:2324907
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
G
MUC5B
mucin 5B, oligomeric mucus/gel-forming
IEP
mRNA:increased expression:pancreas
RGD
PMID:7657125
RGD:2324986
NCBI chr11:1,223,066...1,262,172
Ensembl chr11:1,223,066...1,262,172
G
NDRG1
N-myc downstream regulated 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16778198
NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022
G
NFE2L2
NFE2 like bZIP transcription factor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21489257
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NME1
NME/NM23 nucleoside diphosphate kinase 1
IEP
protein:increased expression:pancreas (human)
RGD
PMID:17492507
RGD:5132867
NCBI chr17:51,153,559...51,162,168
Ensembl chr17:51,153,559...51,162,428
G
NOS2
nitric oxide synthase 2
ISO
RGD
PMID:12660813
RGD:2325254
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOTCH1
notch receptor 1
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19208345 PMID:20484026 PMID:19028876
RGD:2325323 , RGD:2325324
NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
G
NOTCH3
notch receptor 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr19:15,159,038...15,200,995
Ensembl chr19:15,159,038...15,200,995
G
NOTCH4
notch receptor 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr 6:32,194,843...32,224,067
Ensembl chr 6:32,194,843...32,224,067
G
NTRK3
neurotrophic receptor tyrosine kinase 3
disease_progression
IEP
protein:increased expression:pancreas
RGD
PMID:10209957 PMID:11295066
RGD:2325663 , RGD:2325660
NCBI chr15:87,859,751...88,256,739
Ensembl chr15:87,859,751...88,256,791
G
OSM
oncostatin M
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24979617
NCBI chr22:30,262,829...30,266,851
Ensembl chr22:30,262,829...30,266,851
G
PALLD
palladin, cytoskeletal associated protein
IEP
protein:increased expression, alternative form:pancreas, fibroblast
RGD
PMID:17404500
RGD:2325781
NCBI chr 4:168,497,052...168,928,441
Ensembl chr 4:168,497,052...168,928,457
G
PAX6
paired box 6
IEP
protein:increased expression:pancreatic duct (human)
RGD
PMID:17849422
RGD:8552381
NCBI chr11:31,789,026...31,817,961
Ensembl chr11:31,784,779...31,817,961
G
PMS1
PMS1 homolog 1, mismatch repair system component
IDA
protein:increased expression:pancreatic duct
RGD
PMID:15856462
RGD:2324870
NCBI chr 2:189,784,450...189,877,629
Ensembl chr 2:189,784,085...189,877,629
G
PPARG
peroxisome proliferator activated receptor gamma
disease_progression
IEP
RGD
PMID:19396032
RGD:2317461
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:18670639
RGD:2317185
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
RELA
RELA proto-oncogene, NF-kB subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34686948
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
RNF2
ring finger protein 2
IEP
protein:increased expression:pancreas
RGD
PMID:19585519
RGD:9491843
NCBI chr 1:185,045,558...185,102,603
Ensembl chr 1:185,045,497...185,102,603
G
RXRA
retinoid X receptor alpha
severity
IEP
RGD
PMID:19396032
RGD:2317461
NCBI chr 9:134,326,455...134,440,585
Ensembl chr 9:134,317,098...134,440,585
G
SERPINA1
serpin family A member 1
IEP
mRNA, protein:increased expression:pancreas
RGD
PMID:12488200
RGD:2317811
NCBI chr14:94,376,747...94,390,635
Ensembl chr14:94,376,747...94,390,693
G
SLC2A2
solute carrier family 2 member 2
ISO
protein:increased expression:pancreatic duct
RGD
PMID:19252908
RGD:2324975
NCBI chr 3:170,996,347...171,026,720
Ensembl chr 3:170,996,347...171,026,743
G
SMAD4
SMAD family member 4
disease_progression
IEP
RGD
PMID:15173084
RGD:21066334
NCBI chr18:51,030,213...51,085,042
Ensembl chr18:51,028,528...51,085,045
G
SMO
smoothened, frizzled class receptor
IMP
RGD
PMID:16826192
RGD:2324981
NCBI chr 7:129,188,633...129,213,545
Ensembl chr 7:129,188,633...129,213,545
G
STK11
serine/threonine kinase 11
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26887594
NCBI chr19:1,205,778...1,228,431
Ensembl chr19:1,177,558...1,228,431
G
TGFB1
transforming growth factor beta 1
disease_progression
IEP
RGD
PMID:16101174
RGD:2325019
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TGFBR2
transforming growth factor beta receptor 2
disease_progression
ISO IEP
mRNA:increased expresssion:pancreas
RGD
PMID:17114585 PMID:10547197
RGD:2317498 , RGD:2317500
NCBI chr 3:30,606,356...30,694,142
Ensembl chr 3:30,606,478...30,694,249
G
THBS1
thrombospondin 1
disease_progression
IEP IDA
DNA:hypermethylation:promoter (human)
RGD
PMID:12429967 PMID:19065635
RGD:2325025 , RGD:2325022
NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466
G
TMPRSS3
transmembrane serine protease 3
IEP
RGD
PMID:14695172
RGD:2325152
NCBI chr21:42,371,890...42,396,052
Ensembl chr21:42,371,887...42,396,091
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29844410
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
G
TSC2
TSC complex subunit 2
severity
IEP
RGD
PMID:16213898
RGD:11568674
NCBI chr16:2,047,985...2,089,491
Ensembl chr16:2,047,967...2,089,491
G
TYMP
thymidine phosphorylase
disease_progression
IEP
RGD
PMID:19760965
RGD:2325155
NCBI chr22:50,525,752...50,530,085
Ensembl chr22:50,525,752...50,530,032
G
VEGFA
vascular endothelial growth factor A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17481528
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VHL
von Hippel-Lindau tumor suppressor
IDA
DNA:hypermethylation:promoter (human)
RGD
PMID:19065635
RGD:2325022
NCBI chr 3:10,141,778...10,153,667
Ensembl chr 3:10,141,778...10,153,667
G
YEATS2
YEATS domain containing 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34686948
NCBI chr 3:183,697,797...183,812,624
Ensembl chr 3:183,697,797...183,812,624
G
ZZZ3
zinc finger ZZ-type containing 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34686948
NCBI chr 1:77,562,416...77,683,398
Ensembl chr 1:77,562,416...77,683,419
G
TGFB2
transforming growth factor beta 2
ameliorates
IMP
human cells in a mouse model
RGD
PMID:21366804
RGD:155630611
NCBI chr 1:218,345,336...218,444,619
Ensembl chr 1:218,345,336...218,444,619
G
AGR2
anterior gradient 2, protein disulphide isomerase family member
IEP
protein:increased expression:pancreas
RGD
PMID:19714807
RGD:2325658
NCBI chr 7:16,791,811...16,804,999
Ensembl chr 7:16,791,811...16,833,433
G
AKR7A2
aldo-keto reductase family 7 member A2
IEP
protein:increased expression:pancreas
RGD
PMID:19077459
RGD:2325696
NCBI chr 1:19,302,708...19,312,146
Ensembl chr 1:19,303,965...19,312,144
G
CALR
calreticulin
ameliorates
IMP
human cells in mouse model human cells in a mouse model
RGD
PMID:33028359 PMID:29072694
RGD:150520160 , RGD:150521706
NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489
G
CCND1
cyclin D1
severity
IAGP IEP
DNA:snp:exon:c.870G>A (human) protein:increased expression:pancreas (human)
RGD
PMID:25470788 PMID:22939953
RGD:13462050 , RGD:13462062
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
G
CD59
CD59 molecule (CD59 blood group)
disease_progression
IEP
protein:increased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr11:33,703,010...33,736,479
Ensembl chr11:33,703,010...33,736,479
G
CDK4
cyclin dependent kinase 4
severity
IEP
protein:increased expression:pancreas, islet of Langerhans (human)
RGD
PMID:29735403
RGD:13781899
NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013
G
CFHR3
complement factor H related 3
disease_progression
IEP
protein:decreased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 1:196,774,840...196,795,407
Ensembl chr 1:196,774,813...196,795,407
G
E2F1
E2F transcription factor 1
severity
IEP IAGP
protein:increased expression:pancreatic ductal cell, nucleus (human) DNA:amplification: : (human)
RGD
PMID:12650514 PMID:17233815 PMID:27573434
RGD:13838735 , RGD:13838739 , RGD:13838738
NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
G
FOXM1
forkhead box M1
disease_progression
IEP
RGD
PMID:24859161
RGD:156430321
NCBI chr12:2,857,680...2,877,174
Ensembl chr12:2,857,680...2,877,174
G
FUBP1
far upstream element binding protein 1
IEP
mRNA:increased expression:pancreatic duct (human)
RGD
PMID:32481602
RGD:151361197
NCBI chr 1:77,944,055...77,979,501
Ensembl chr 1:77,944,055...77,979,110
G
GLIPR2
GLI pathogenesis related 2
disease_progression
IEP
protein:decreased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 9:36,136,536...36,163,913
Ensembl chr 9:36,136,536...36,163,913
G
GOT1
glutamic-oxaloacetic transaminase 1
treatment
IMP
human cells in a mouse model
RGD
PMID:23535601
RGD:13504844
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
G
HSPA8
heat shock protein family A (Hsp70) member 8
disease_progression
IEP
protein:decreased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
G
IKBKB
inhibitor of nuclear factor kappa B kinase subunit beta
susceptibility
ISO
RGD
PMID:22264792
RGD:13838741
NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
G
JAK1
Janus kinase 1
IEP
mRNA:decreased expression:pancreatic ductal cell (human)
RGD
PMID:28677798
RGD:13838745
NCBI chr 1:64,833,229...65,067,746
Ensembl chr 1:64,833,223...65,067,754
G
MAPK8
mitogen-activated protein kinase 8
severity disease_progression
ISO
protein:increased phosphorylation:pancreas (mouse)
RGD
PMID:28837246 PMID:23237571
RGD:14348974 , RGD:14348975
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
G
MIR155
microRNA 155
disease_progression
IEP
RGD
PMID:28198398
RGD:25314300
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
G
MIR494
microRNA 494
disease_progression ameliorates
IEP IDA
RGD
PMID:24859161 PMID:24859161
RGD:156430321 , RGD:156430321
NCBI chr14:101,029,634...101,029,714
Ensembl chr14:101,029,634...101,029,714
G
PGF
placental growth factor
severity
ISO
associated with obesity
RGD
PMID:26861455
RGD:14349030
NCBI chr14:74,941,830...74,955,764
Ensembl chr14:74,941,834...74,955,626
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
IEP
mRNA, protein:increased expression:pancreas (human)
RGD
PMID:20876794
RGD:14390130
NCBI chr 7:106,865,282...106,908,980
Ensembl chr 7:106,865,278...106,908,980
G
PIK3R2
phosphoinositide-3-kinase regulatory subunit 2
severity
IMP
human cells in a mouse model
RGD
PMID:15591514
RGD:14390084
NCBI chr19:18,153,163...18,170,532
Ensembl chr19:18,153,163...18,170,532
G
PLD1
phospholipase D1
severity
IEP
protein:increased expression:pancreas (human)
RGD
PMID:27713167
RGD:14392801
NCBI chr 3:171,600,404...171,810,483
Ensembl chr 3:171,600,404...171,810,950
G
PTPRB
protein tyrosine phosphatase receptor type B
disease_progression
IEP
protein:decreased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr12:70,515,870...70,637,429
Ensembl chr12:70,515,870...70,637,440
G
PTPRM
protein tyrosine phosphatase receptor type M
disease_progression
IEP
protein:decreased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr18:7,567,316...8,406,856
Ensembl chr18:7,566,782...8,406,861
G
RAC1
Rac family small GTPase 1
IEP ISO
mRNA:increased expression:pancreas (human) mRNA, protein:increased expression:pancreas (mouse)
RGD
PMID:23334332 PMID:21684285
RGD:14392806 , RGD:14392816
NCBI chr 7:6,374,527...6,403,967
Ensembl chr 7:6,374,527...6,403,967
G
RALA
RAS like proto-oncogene A
IEP
mRNA:increased expression:pancreas (human)
RGD
PMID:29113235
RGD:14394418
NCBI chr 7:39,623,572...39,708,120
Ensembl chr 7:39,623,565...39,708,120
G
S100A8
S100 calcium binding protein A8
disease_progression
IEP
protein:increased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 1:153,390,032...153,422,583
Ensembl chr 1:153,390,032...153,391,073
G
SMAD2
SMAD family member 2
severity
IEP
RGD
PMID:26908446
RGD:14394493
NCBI chr18:47,808,957...47,930,872
Ensembl chr18:47,808,957...47,931,146
G
TGFB1
transforming growth factor beta 1
ameliorates
IEP
protein:decreased expression:pancreas (human)
RGD
PMID:8253361
RGD:155630628
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TGFB2
transforming growth factor beta 2
ameliorates
IEP
protein:decreased expression:pancreas (human)
RGD
PMID:8253361
RGD:155630628
NCBI chr 1:218,345,336...218,444,619
Ensembl chr 1:218,345,336...218,444,619
G
TGFB3
transforming growth factor beta 3
ameliorates
IEP
protein:decreased expression:pancreas (human)
RGD
PMID:8253361
RGD:155630628
NCBI chr14:75,958,097...75,983,011
Ensembl chr14:75,958,097...75,983,011
G
TGFBR1
transforming growth factor beta receptor 1
ameliorates
IMP
human cell line in a mouse model
RGD
PMID:17297450
RGD:155630637
NCBI chr 9:99,103,647...99,154,192
Ensembl chr 9:99,104,038...99,154,192
G
VEGFD
vascular endothelial growth factor D
IEP
protein:increased expression:blood serum (human)
RGD
PMID:21410412
RGD:155630646
NCBI chr X:15,345,596...15,384,413
Ensembl chr X:15,345,596...15,384,413
G
VNN1
vanin 1
disease_progression
IEP
protein:increased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 6:132,680,849...132,714,055
Ensembl chr 6:132,680,849...132,714,055
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all